BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 18556186)

  • 1. Acute toxicity and 2-year adverse effects of 30 Gy in five fractions over 15 days to whole breast after local excision of early breast cancer.
    Martin S; Mannino M; Rostom A; Tait D; Donovan E; Eagle S; Haviland J; Yarnold J
    Clin Oncol (R Coll Radiol); 2008 Sep; 20(7):502-5. PubMed ID: 18556186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer.
    Benitez PR; Keisch ME; Vicini F; Stolier A; Scroggins T; Walker A; White J; Hedberg P; Hebert M; Arthur D; Zannis V; Quiet C; Streeter O; Silverstein M
    Am J Surg; 2007 Oct; 194(4):456-62. PubMed ID: 17826055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy.
    Donovan E; Bleakley N; Denholm E; Evans P; Gothard L; Hanson J; Peckitt C; Reise S; Ross G; Sharp G; Symonds-Tayler R; Tait D; Yarnold J;
    Radiother Oncol; 2007 Mar; 82(3):254-64. PubMed ID: 17224195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of electron beam treatment in postoperative management of carcinoma of the breast.
    Vishwanathan N; Bhaskar N; Supe SS; Swamy K; Ravichandran R; Kannan V; Ramesh C
    Indian J Cancer; 1998 Mar; 35(1):1-9. PubMed ID: 9847464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute effects of postmastectomy radiotherapy after immediate TRAM flap reconstruction in breast cancer patients.
    Sitathanee C; Puataweepong P; Swangsilpa T; Narkwong L; Kongdan Y; Suvikapakornkul R
    J Med Assoc Thai; 2005 Dec; 88(12):1861-6. PubMed ID: 16518986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective evaluation of concomitant tumour bed boost with whole breast irradiation in patients with locally advanced breast cancer undergoing breast-conserving therapy.
    Jalali R; Malde R; Bhutani R; Budrukkar A; Badwe R; Sarin R
    Breast; 2008 Feb; 17(1):64-70. PubMed ID: 17851077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results of adjuvant hypofractionated radiotherapy for breast cancer in elderly patients.
    Ortholan C; Hannoun-Lévi JM; Ferrero JM; Largillier R; Courdi A
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):154-62. PubMed ID: 15629606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interim cosmetic results and toxicity using 3D conformal external beam radiotherapy to deliver accelerated partial breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy.
    Vicini FA; Chen P; Wallace M; Mitchell C; Hasan Y; Grills I; Kestin L; Schell S; Goldstein NS; Kunzman J; Gilbert S; Martinez A
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1124-30. PubMed ID: 17967306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: toxicity analysis of RTOG 95-17.
    Kuske RR; Winter K; Arthur DW; Bolton J; Rabinovitch R; White J; Hanson W; Wilenzick RM
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):45-51. PubMed ID: 16503383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraoperative radiotherapy given as a boost for early breast cancer: long-term clinical and cosmetic results.
    Lemanski C; Azria D; Thezenas S; Gutowski M; Saint-Aubert B; Rouanet P; Fenoglietto P; Ailleres N; Dubois JB
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1410-5. PubMed ID: 16442241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.
    Trombetta M; Julian TB; Werts DE; McWilliams W; Kim Y; Miften M; Parda D
    Am J Clin Oncol; 2009 Jun; 32(3):314-8. PubMed ID: 19451803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute toxicity of high-dose-rate intracavitary brachytherapy with the MammoSite applicator in patients with early-stage breast cancer.
    Richards GM; Berson AM; Rescigno J; Sanghavi S; Siegel B; Axelrod D; Bernik S; Scarpinato V; Mills C
    Ann Surg Oncol; 2004 Aug; 11(8):739-46. PubMed ID: 15249336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Four-week course of radiation for breast cancer using hypofractionated intensity modulated radiation therapy with an incorporated boost.
    Freedman GM; Anderson PR; Goldstein LJ; Ma CM; Li J; Swaby RF; Litwin S; Watkins-Bruner D; Sigurdson ER; Morrow M
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):347-53. PubMed ID: 17379430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensity modulated radiation therapy (IMRT) decreases acute skin toxicity for women receiving radiation for breast cancer.
    Freedman GM; Anderson PR; Li J; Eisenberg DF; Hanlon AL; Wang L; Nicolaou N
    Am J Clin Oncol; 2006 Feb; 29(1):66-70. PubMed ID: 16462506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caesium(137) implant as sole radiation therapy for operable breast cancer: a phase II trial.
    Fentiman IS; Deshmane V; Tong D; Winter J; Mayles H; Chaudary MA
    Radiother Oncol; 2004 Jun; 71(3):281-5. PubMed ID: 15172143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerance and acceptance results of a palladium-103 permanent breast seed implant Phase I/II study.
    Pignol JP; Rakovitch E; Keller BM; Sankreacha R; Chartier C
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1482-8. PubMed ID: 18930602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathological risk factors for ipsilateral breast events after breast conserving treatment for ductal carcinoma in situ of the breast--results from the Swedish randomised trial.
    Ringberg A; Nordgren H; Thorstensson S; Idvall I; Garmo H; Granstrand B; Arnesson LG; Sandelin K; Wallgren A; Anderson H; Emdin S; Holmberg L
    Eur J Cancer; 2007 Jan; 43(2):291-8. PubMed ID: 17118648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome and toxicity in a Phase I/II trial using high-dose-rate multicatheter interstitial brachytherapy for T1/T2 breast cancer.
    Kaufman SA; DiPetrillo TA; Price LL; Midle JB; Wazer DE
    Brachytherapy; 2007; 6(4):286-92. PubMed ID: 17991625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary results of electron intraoperative therapy boost and hypofractionated external beam radiotherapy after breast-conserving surgery in premenopausal women.
    Ivaldi GB; Leonardi MC; Orecchia R; Zerini D; Morra A; Galimberti V; Gatti G; Luini A; Veronesi P; Ciocca M; Sangalli C; Fodor C; Veronesi U
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):485-93. PubMed ID: 18407434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in patterns of failure in patients treated with accelerated partial breast irradiation versus whole-breast irradiation: a matched-pair analysis with 10-year follow-up.
    Antonucci JV; Wallace M; Goldstein NS; Kestin L; Chen P; Benitez P; Dekhne N; Martinez A; Vicini F
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):447-52. PubMed ID: 19058921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.